Adding patent foramen ovale closure to antiplatelet therapy reduced stroke after cryptogenic stroke
- PMID: 29335719
- DOI: 10.7326/ACPJC-2018-168-2-007
Adding patent foramen ovale closure to antiplatelet therapy reduced stroke after cryptogenic stroke
Comment on
-
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915. N Engl J Med. 2017. PMID: 28902593 Clinical Trial.
Similar articles
-
close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.Int J Stroke. 2016 Aug;11(6):724-32. doi: 10.1177/1747493016643551. Epub 2016 Apr 7. Int J Stroke. 2016. PMID: 27056964 Clinical Trial.
-
Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.Int J Stroke. 2017 Dec;12(9):998-1004. doi: 10.1177/1747493017701152. Epub 2017 Mar 24. Int J Stroke. 2017. PMID: 29090661 Clinical Trial.
-
Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?Am J Med. 2016 Nov;129(11):1159-1162. doi: 10.1016/j.amjmed.2016.08.006. Epub 2016 Aug 24. Am J Med. 2016. PMID: 27566504 Review.
-
Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.Am J Med. 2018 May;131(5):575-577. doi: 10.1016/j.amjmed.2017.11.027. Epub 2017 Dec 8. Am J Med. 2018. PMID: 29229471 Free PMC article.
-
Adding patent foramen ovale closure to antiplatelet drugs reduced ischemic stroke after cryptogenic stroke.Ann Intern Med. 2018 Jan 16;168(2):JC6. doi: 10.7326/ACPJC-2018-168-2-006. Ann Intern Med. 2018. PMID: 29335718 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical